These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 30135271)

  • 1. Development and validation of a tool to identify barriers to starting insulin treatment in patients with type-2 diabetes mellitus.
    Fu SN; Chin WY; Wong CK; Yeung VT; Yiu MP; Tsui HY; Chan KH
    Hong Kong Med J; 2018 Aug; 24 Suppl 4(4):24-29. PubMed ID: 30135271
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of insulin pen devices on the management of diabetes mellitus.
    Meece J
    Am J Health Syst Pharm; 2008 Jun; 65(11):1076-82. PubMed ID: 18499883
    [No Abstract]   [Full Text] [Related]  

  • 3. [Optimal therapeutic strategy in type 2 diabetes mellitus].
    Scherbaum WA; Nitschmann S
    Internist (Berl); 2009 Feb; 50(2):244-8. PubMed ID: 19183919
    [No Abstract]   [Full Text] [Related]  

  • 4. DialBetics: Smartphone-Based Self-Management for Type 2 Diabetes Patients on Insulin Injections.
    Waki K; Fujiu K; Hayashi A; Kimura S; Kobayashi H; Nangaku M; Kadowaki T; Ohe K
    J Diabetes Sci Technol; 2016 May; 10(3):804-5. PubMed ID: 27460625
    [No Abstract]   [Full Text] [Related]  

  • 5. Refill compliance in type 2 diabetes mellitus: a predictor of switching to insulin therapy?
    Spoelstra JA; Stolk RP; Heerdink ER; Klungel OH; Erkens JA; Leufkens HG; Grobbee DE
    Pharmacoepidemiol Drug Saf; 2003 Mar; 12(2):121-7. PubMed ID: 12642975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Starting insulin.
    Berg EG
    Diabetes Forecast; 2014 Apr; 67(4):26, 28-9. PubMed ID: 24783691
    [No Abstract]   [Full Text] [Related]  

  • 7. [The treatment of diabetes mellitus in the elderly: pill or pen?].
    Ned Tijdschr Geneeskd; 1989 Aug; 133(34):1706. PubMed ID: 2677786
    [No Abstract]   [Full Text] [Related]  

  • 8. Uncomplicating insulin therapy: strategies for initiation in patients with type 2 diabetes.
    Kapustin JF
    Adv NPs PAs; 2012 May; 3(5):20-6; quiz 27. PubMed ID: 22670303
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhaled insulin product approved.
    Traynor K
    Am J Health Syst Pharm; 2014 Aug; 71(15):1238. PubMed ID: 25027522
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive insulin therapy in newly diagnosed type 2 diabetes.
    Retnakaran R; Drucker DJ
    Lancet; 2008 May; 371(9626):1725-6. PubMed ID: 18502278
    [No Abstract]   [Full Text] [Related]  

  • 11. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 12. Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.
    Martinez L; Consoli SM; Monnier L; Simon D; Wong O; Yomtov B; Guéron B; Benmedjahed K; Guillemin I; Arnould B
    Health Qual Life Outcomes; 2007 Aug; 5():53. PubMed ID: 17727695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin treatment for type 2 diabetes: when to start, which to use.
    Hamaty M
    Cleve Clin J Med; 2011 May; 78(5):332-42. PubMed ID: 21536829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intensive insulin therapy].
    Landgraf R; Huber RM; Bachmann A; Lohr R
    Dtsch Med Wochenschr; 2008 Apr; 133(17):901-12. PubMed ID: 18415916
    [No Abstract]   [Full Text] [Related]  

  • 15. Whenever you lose connection, take intranasal insulin?
    Gottschalk A; Ellger B
    Diabetes; 2015 Mar; 64(3):687-8. PubMed ID: 25713190
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
    Pham DQ; Cohen H; Chu V
    J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of preference for NovoPen(®) 4 with previous insulin pen treatments after 12 weeks in adult patients with type 1 and type 2 diabetes: a multicenter observational study.
    Israël-Bultman H; Hyllested-Winge J; Kolaczynski M; Steindorf J; Garon J
    Clin Ther; 2011 Mar; 33(3):346-57. PubMed ID: 21600387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Better metabolic control with patient-focused insulin administration].
    Med Monatsschr Pharm; 2005 Oct; 28(10):366. PubMed ID: 16245457
    [No Abstract]   [Full Text] [Related]  

  • 19. Removing barriers to insulin therapy.
    Peragallo-Dittko V
    Diabetes Educ; 2007; 33 Suppl 3():60S-65S. PubMed ID: 17426309
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.
    Rubin RR; Peyrot M; Chen X; Frias JP
    Diabetes Technol Ther; 2010 Nov; 12(11):901-6. PubMed ID: 20879963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.